by reason for retraction – Page 25

Extensive correction adds to five flagged papers for UPenn professor

A UPenn professor now has six papers with a correction, expression of concern, or retraction in two PLOS journals after one published an extensive correction to a 2018 paper.

The correction adds to two retractions and three expressions of concern for papers in PLOS Pathogens and PLOS ONE with Erle Robertson, a microbiology professor and vice chair of research for the department of otorhinolaryngology at the University of Pennsylvania, as a senior author. The actions on each paper happened after commenters on PubPeer pointed out issues.

The correction to “STAT6 degradation and ubiquitylated TRIML2 are essential for activation of human oncogenic herpesvirus” states:

Medical school dean up to five retractions

A kidney research group led by a medical school dean has accumulated five retractions.

All five came within the last year, after commenters on PubPeer pointed out image similarities.

Joseph I. Shapiro, vice president and dean of the Joan C. Edwards School of Medicine of Marshall University in Huntington, West Virginia, is an author on each of the five papers and corresponding author for two. (Shapiro recently said he will be stepping down at the end of this month after ten years as dean, but will remain a tenured professor, according to a news report.)

A stolen manuscript, part two: The plagiarist begs for forgiveness as another group plagiarizes the same work

In 2019, we wrote about a reviewer who stole a manuscript and published it under his own name. Today, we bring you the sequel.

The sequel involves a plea for forgiveness after the plagiarized paper was retracted, and a second allegation of stealing work – which has prompted the target of the plagiarism to wonder if a more serious response from the journal to the first instance would have discouraged the second.

We obtained an email the reviewer, Yuvarajan Devarajan, sent after the retraction to Mina Mehregan, a mechanical engineer at Ferdowsi University of Mashhad in Iran whose work he copied. In it, he explains what happened, and asks, beginning in all caps in the subject line, for her to “FORGIVE ME IF POSSIBLE”:

A hare-raising expression of concern after an author hires a third party to get a paper published

An Elsevier journal has issued a rather remarkable expression of concern for a 2021 paper on rabbit husbandry after learning that the lead author misrepresented the authorship of the article – and possibly more.

The paper, “Supplementing rabbit diets with butylated hydroxyanisole affects oxidative stress, growth performance, and meat quality,” appeared in animal and ostensibly came from a group in Egypt and Saudi Arabia led by Tharwat Imbabi.

But as the journal explains, the article wasn’t the first rabbit rodeo for Imbabi, of the department of animal production at Benha University. According to the notice, the researcher had failed repeatedly to publish his manuscript in other journals, so he turned to “third parties” for help.

Those contributors did the bulk of the work – but wanted none of the credit. Meanwhile, Imbabi appears to have found other authors willing to join the list.

We’ll let the expression of concern tell the rest:

Urology researcher under investigation for double-dipping has another paper retracted

A urology researcher who stepped down from his post as department chair after an institutional investigation prompted by Retraction Watch reporting has lost another paper.

The article apparently was not flagged during a misconduct investigation, but a PubPeer commenter noted overlapping images in August 2021.

Hari Koul had been interim chair of the department of biochemistry and molecular biology at LSU Health New Orleans until last December. He stepped down from the post (but remains a professor) amid the university’s investigation of allegations that he secured grants from two federal agencies for the same research project, following reporting by Retraction Watch in October.

An LSU Health New Orleans spokesperson told Retraction Watch the “process has not been completed.”

‘Inadvertently published’ paper by pharma employee retracted almost a year later

A Takeda employee has lost a 2021 paper that the journal says it “inadvertently published.”

The article, “Seasonal and Secular Periodicities Identified in the Dynamics of US FDA Medical Devices (1976–2020): Portends Intrinsic Industrial Transformation and Independence of Certain Crises,” appeared in Therapeutic Innovation & Regulatory Science. It has yet to be cited, according to Clarivate Analytics’ Web of Science

The retraction notice from a few days ago says, in full:

Drug researchers in Russia have four papers subjected to expressions of concern

A psychiatry journal has issued expressions of concern for four papers by a group of researchers in Russia after questions surfaced about the integrity of the data.

The first author on all of the papers was Ilya D. Ionov, of the Centre On Theoretical Problems in Physical and Chemical Pharmacology, part of the Russian Academy of Sciences in Moscow. The co-authors are affiliated with Timpharm LTD, a drug company without much in the way of an online presence.

The papers appeared in Psychopharmacology, a Springer Nature title.

Here’s the notice for “Anticataleptic activity of nicotine in rats: involvement of the lateral entorhinal cortex,” which Psychopharmacology published in 2021:

The “internet may be a challenging venue”: Biomedical engineering group up to four retractions

A group of biomedical engineering researchers has lost four papers because they appear to be recycling their images from other papers.

The retractions for the group, from Banaras Hindu University in India, span papers published between 2011 and 2014. The retractions began in 2020, after anonymous PubPeer commenters pointed out the similarities between images. The four papers have been cited a total of 140 times, according to Clarivate Analytics’ Web of Science.

The latest paper to be retracted, “Alleviation of glutamate-mediated neuronal insult by piroxicam in rodent model of focal cerebral ischemia: a possible mechanism of GABA agonism,” was originally published in Springer Nature’s Journal of Physiology and Biochemistry in 2014. It has been cited 12 times.

According to the retraction notice:

How citation cartels give ‘strategic scholars’ an advantage: A simple model

Sincere scholars work to expand society’s knowledge and understanding. They cite all the relevant research, even that produced by those they disagree with or personally dislike. They encourage debate. For the sincere scholar, a citation is a responsibility, and proper and thorough citations demonstrate research quality.

For the strategic scholar, a citation is an asset to be used career-advantageously. As a certain former governor of the State of Illinois once said about his responsibility to fill an open US senate position, “I’ve got this thing and it’s (expletive) golden. I’m not just giving it up for (expletive) nothing.”

Strategic scholars cite the work of their friends, working colleagues, those they agree with, and those who reference them. Indeed, the most successful career-strategic scholars operate in groups of like-minded colleagues in which they promote each other’s careers together—citation cartels. They draw attention to that other work which supports their own and their careers.

Journal retracts paper listed on authorship for sale site following Retraction Watch report

An Elsevier journal has retracted a paper that was listed by a firm claiming to sell authorships months after we reported on the site.

On Sept. 7, 2021, we published a story about the company, Teziran. On Sept. 14, pseudonymous sleuth Artemisia Stricta wrote to Ioannis Ieropoulos, the editor of Sustainable Energy Technologies and Assessments, which had published one of eight papers listed by Teziran as “ready for acceptance”:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: